Related Experiment Video
Updated: May 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Anti-atherosclerotic mechanisms of statin therapy
Andrea Babelova1, Daniel G Sedding, Ralf P Brandes
1Institut für Kardiovaskuläre Physiologie, Goethe-Universität, Frankfurt, Germany.
Abstract:
HMG-CoA-Reductase inhibitors, also known as statins, are currently the most powerful cholesterol-lowering drugs available on the market. Clinical trials and experimental evidence suggest that statins have anti-atherosclerotic effects. These are in part consequence of lipid lowering but also result from pleiotropic actions of the drugs. In this article, the anti-atherosclerotic actions of statins will be reviewed.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System